Clonidine 0.075 mg (75 µg) for Hypertension: Dosing and Titration
Start with clonidine 0.1 mg twice daily (morning and bedtime), not 0.075 mg, as this is the FDA-approved initial dose and the lowest effective starting point for blood pressure control. 1
Starting Dose
The FDA-approved initial dose for clonidine is 0.1 mg twice daily (morning and bedtime), not 0.075 mg 1. While 0.075 mg has been studied in research settings 2, the standard clinical starting dose remains 0.1 mg BID. Elderly patients may benefit from a lower initial dose, but this should still be discussed with consideration of the 0.1 mg starting point 1.
Titration Schedule
- Week 1-2: Begin with 0.1 mg twice daily (morning and bedtime)
- Subsequent weeks: Increase by 0.1 mg per day at weekly intervals if blood pressure control is inadequate 1
- Maintenance range: Most patients respond to 0.2-0.6 mg per day in divided doses 1
- Maximum dose: 2.4 mg daily (though rarely needed) 1
Dosing Strategy for Better Tolerability
Taking the larger portion of the daily dose at bedtime minimizes daytime side effects (dry mouth, drowsiness) 1. Research supports asymmetric dosing schedules:
- Consider 0.075 mg in the morning and 0.15 mg at bedtime for better blood pressure control with reduced daytime sedation 2, 3
- Avoid giving the evening dose too late (10 PM) as this causes significant diastolic blood pressure rise by 8 PM the next day 2
- Optimal timing: Morning dose at 8 AM, evening dose at 4-6 PM 2, 3
Critical Safety Considerations
Important Caveats About Clonidine
Clonidine is reserved as a last-line agent due to significant CNS adverse effects, especially in older adults 4, 5, 6, 7. The 2017 ACC/AHA guidelines explicitly state this limitation across multiple publications.
Mandatory Precautions
- Never stop abruptly: Clonidine must be tapered to avoid rebound hypertensive crisis 4, 5, 6, 7
- Perioperative risk: Withdrawal syndromes with sympathetic discharge can occur if stopped acutely during surgery 8
- Renal impairment: Lower initial doses needed; minimal removal during hemodialysis (no supplemental dosing required) 1
Why Not First-Line?
The 2017 ACC/AHA guidelines consistently classify clonidine as a central alpha-2 agonist reserved for last-line therapy due to:
- Significant CNS adverse effects (sedation, dry mouth, drowsiness)
- Particularly problematic in older adults
- Risk of hypertensive crisis with abrupt discontinuation 4, 5, 6, 7
Alternative Considerations
If the patient cannot tolerate labetalol or nifedipine, consider other first-line agents before resorting to clonidine:
- ACE inhibitors or ARBs
- Thiazide or thiazide-like diuretics
- Other calcium channel blockers (amlodipine, diltiazem)
These have better safety profiles and are recommended as first-line therapy 4, 9.